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Several of the identiﬁed genes such as PTGES and FRZB were previously
found to mark OA in expression analyses and/or genetic association
studies. Remarkably, we identiﬁed several genes which regulate nerve
growth processes to be up-regulated in the OA affected areas. This ﬁnding
raises the question whether increasing pain signals at OA lesions may
confer risk to joint replacement surgery.
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GENETIC POLYMORPHISMS OF TUMOR NECROSIS FACTOR ALPHA GENE
AND SUSCEPTIBILITY TO HAND OSTEOARTHRITIS IN FINNISHWOMEN
S. Ha¨ma¨la¨inen, S. Solovieva, T. Vehmas, P. Leini-Arjas, A. Hirvonen.
Finnish Inst. of Occupational Hlth., Helsinki, Finland
Purpose: Osteoarthritis (OA) is a common disease characterised by
degeneration of the cartilage of synovial joints. Available evidence
suggests that genetic factors may play a major role in the etiology
of OA. Since Tumor necrosis factor alpha (TNFa) has been shown to be
produced more in OA cartilage than in normal cartilage, it is a good
candidate for these genetic factors. We examined this by studying the
role of four single nucleotide polymorphisms (SNPs) (rs1799964 "-1031",
rs1800630 "-863", rs1799724 "-857" and rs1800629 "-308") in TNFa gene
and their haplotypes in the individual susceptibility to hand OA in Finnish
women.
Methods: Bilateral hand radiographs of 543 Finnish female dentists and
teachers aged 45–63 years and living in the Helsinki metropolitan region
were examined and classiﬁed for the presence of OA using a modiﬁed
Kellgren-Lawrence (K-L) system and reference images. Hand OA was
deﬁned as at least mild (K-L > 2) symptomatic distal interphalangeal
(DIP) hand OA in at least 2 ﬁnger joints (symptDIP OA 2+ >2). The
genotypes were determined by PCR-based methods. Data regarding other
risk factors were collected by questionnaire. Association between the
genotypes/haplotypes and hand OA were studied by logistic regression
with SPSS statistical package Version 18.0. Haplotypes were analysed
with Haploview program and reconstructed with PHASE
Results: According to power calculations, this study had 80% power to
detect ORs from 2.7 to 4.0 depending on the minor allele frequency
(6–18%), based on a two-sided alpha of 0.05.
The prevalence of symptDIP OA 2+ >2 was 9%, (6.8% in dentists, 11.7% in
teachers). The genotype frequencies were in Hardy-Weinberg equilibrium
in all studied polymorphic loci. An association was found between the
TNFa −1031 and −863 loci’s minor allele carriage (C-allele in −1031
and A-allele in −863) and symptDIP OA 2+ >2 when adjusted for age,
occupation and BMI. The minor allele in −1031 locus posed a borderline
signiﬁcant risk in total sample (OR 1.76 95% CI 0.95–3.29). When stratiﬁed
by occupation an almost 3-fold risk (OR 2.81, 95% CI 1.06–7.45) was seen
in dentists whereas no statistically signiﬁcant association was seen in
teachers (OR 1.30, 95% CI 0.57–2.95). Similarly, carriage of the minor allele
in −863 locus posed an over 2-fold risk in total sample (OR 2.13, 95% CI
1.14–4.00), and when stratiﬁed by occupation the risk was over 3-fold in
dentists (OR 3.40, 95% CI 1.27–9.13) whereas no statistically signiﬁcant
association was seen in teachers (OR 1.56, 95% CI 0.68–3.56).
Haplotype analyses revealed a LD between the TNFa −1031 and −863 loci
(D’ 1.0; r2 0.86). The most common haplotype was TC (82%), followed by
CA (17%) and CC (2%). The haplotype analysis gave similar results to the
genotype analyses; the CA-haplotype showed association to symptDIP
OA 2+ >2 when adjusted for age, occupation and BMI (OR 1.80 95% CI
1.06–3.08). When stratiﬁed by occupation the dentists had an over 2-fold
risk (OR 2.29 95% CI 1.01–5.20) whereas no signiﬁcant risk was seen in
teachers (OR 1.54 95% CI 0.76–3.13).
Conclusions: Our results suggest that the TNFa gene polymorphisms
may play a role in the etiology of hand OA.
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GENOME-WIDE ASSOCIATION STUDY TO IDENTIFY NEW GENES AND
PATHWAYS CONFERRING RISK TO OA SUSCEPTIBILITY IN MULTIPLE
JOINT LOCATIONS AS DEFINED IN THE GARP STUDY
Y.F. Ramos1, S.D. Bos1, U. Styrkarsdottir2, K. Panoutsopoulou3,
C. Keurentjes4, N. Lakenberg1, R. Nelissen4, M. Kloppenburg5, H. Kroon6,
A. Uitterlinden7,8, J. Loughlin9,3, E. Zeggini3, I. Jonsdottir2, J.B. van
Meurs7,8, P.E. Slagboom1,8, I. Meulenbelt1,8. 1Section of Molecular
Epidemiology, LUMC, Leiden, Netherlands; 2deCODE Genetics, Reykjavik,
Iceland; 3arcOGEN Consortium, Cambridge, United Kingdom; 4Dept. of
Orthopaedics, LUMC, Leiden, Netherlands; 5Dept. of Rheumatology &
Clinical Epidemiology, LUMC, Leiden, Netherlands; 6Dept. of Radiology,
LUMC, Leiden, Netherlands; 7Dept. of Internal Med., Erasmus MC,
Rotterdam, Netherlands; 8The Netherlands Genomics Initiative, NCHA,
Leiden-Rotterdam, Netherlands; 9Newcastle Univ., Musculoskeletal Res.
Group, Newcastle, United Kingdom
Purpose: Identify, by genome wide association (GWAS), common OA
susceptibility loci conferring risk to OA at multiple joint locations as
deﬁned in the GARP study.
Methods: A genome wide scan was performed by applying the
Illumina Human660W in the GARP study (N=380) and random controls
(N=1670). The GARP study consists of sibling pairs with symptomatic
OA at multiple joint locations at relative young age (40–70 yrs). This
relatively severe phenotype with familial background may help to stratify
OA into a genetically homogeneous subset, thereby enhancing power
and allowing identiﬁcation of variants with larger impact. Putative OA
susceptibility loci with P-values≤10−5 were replicated both in silico (3
datasets for multiple joint OA, total N =796 cases and 44088 controls) and
by de novo genotyping (N=400). Pathway analysis was performed with
the top 200 loci of the GARP genome wide scan by applying the Database
for Annotation, Visualization and Integrated Discovery (DAVID).
Results: Our analyses resulted in 3 loci at 6q21 (106 Mb), 7q35 (146 Mb)
and 15q26 (91 Mb) that confer consistent risk to OA at multiple joint
locations with an overall P-value <10−4 in the meta-analysis. Pathway
analysis indicated a signiﬁcant involvement of genes expressed during
development.
Conclusions: Although 3 loci showed consistent association to OA at
multiple joint locations, none passed the genome-wide signiﬁcance level
(P-value <10−8). Further analyses are necessary to conﬁrm whether these
putative loci confer risk to our speciﬁc OA phenotype. In addition, we
would like to investigate whether these loci also play a role in more
common OA subtypes by analyses in much larger datasets. Our pathway
analyses supported the hypothesis of OA being a disease with an early
developmental component.
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COMMON VARIANTS IN SKELETAL DYSPLASIA GENES ARE ASSOCIATED
WITH OSTEOARTHRITIS
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K. Panoutsopoulou6, U. Styrkarsdottir7, Y. Zhu8, A. Cupples8, D. Felson8,
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Purpose: To ﬁnd novel genes involved in osteoarthritis (OA) by studying
common genetic variation in genes that have previously been identiﬁed
to cause rare skeletal (dysplasia) syndromes, for example achondroplasia
or Stickler syndrome.
Methods: All known genes causing skeletal (dysplasia) syndromes
were selected based 2 criteria: 1. A list of genes selected from the
